EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACW and the CUSIP is G3167F128. A total of 24 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $9,304 | +132.6% | 37,216 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | -33.3% | 37,216 | 0.0% | 0.00% | – |
| Q2 2022 | $6,000 | -14.3% | 37,216 | 0.0% | 0.00% | – |
| Q1 2022 | $7,000 | -68.2% | 37,216 | 0.0% | 0.00% | – |
| Q4 2021 | $22,000 | +4.8% | 37,216 | 0.0% | 0.00% | – |
| Q3 2021 | $21,000 | +90.9% | 37,216 | +234.9% | 0.00% | – |
| Q2 2021 | $11,000 | – | 11,111 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |